Search

everythinglearnresearchcommunity

for

Search:↓

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Hsc70 protein may influence hair growth by responding to androgens.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The mouse models are effective for testing new hair loss treatments.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Fulvestrant at 10 mg/kg does not promote hair regrowth in dogs with alopecia X.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Aryl hydrocarbon receptor overexpression found in miniaturized hair follicles in female hair loss.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Finasteride safely lowers DHT levels without affecting testosterone.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.